Drugs / IHL-675A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05942911 | Nov 2023 → Oct 2024 | rheumatoid arthritis | Incannex Healthcare Ltd | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IHL-675A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05942911 ↗ |